| pubmed-article:18230277 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C0015684 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C0202042 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C1256369 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C0427743 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C0311187 | lld:lifeskim |
| pubmed-article:18230277 | lifeskim:mentions | umls-concept:C1287281 | lld:lifeskim |
| pubmed-article:18230277 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18230277 | pubmed:dateCreated | 2008-1-30 | lld:pubmed |
| pubmed-article:18230277 | pubmed:abstractText | We investigated the effects of high-monounsaturated fatty acid (MUFA) versus high-carbohydrate enteral formula on post-prandial plasma glucose concentration and insulin response in Japanese patients with type 2 diabetes mellitus and healthy Japanese volunteers. Ten healthy volunteers aged 20.8 +/- 1.2 years and 12 diabetic patients with good glycaemic control (glycosylated haemoglobulin < 7%) aged 58.6 +/- 7.7 years were randomly assigned to take high-MUFA or high-carbohydrate formula after a 12-h overnight fast. The patients switched to the other formula after 7 days. Post-prandial plasma glucose and insulin response were significantly lower in all subjects after taking high-MUFA formula compared with high-carbohydrate formula. No differences were observed in free fatty acids, triglycerides and plasma glucagon between the two diet groups. In conclusion, a high-MUFA enteral formula suppresses post-prandial hyperglycaemia without exaggerated insulin secretion compared with a high-carbohydrate enteral diet in patients with type 2 diabetes and healthy subjects. | lld:pubmed |
| pubmed-article:18230277 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18230277 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18230277 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18230277 | pubmed:issn | 0300-0605 | lld:pubmed |
| pubmed-article:18230277 | pubmed:author | pubmed-author:IshiiHH | lld:pubmed |
| pubmed-article:18230277 | pubmed:author | pubmed-author:YokoyamaJJ | lld:pubmed |
| pubmed-article:18230277 | pubmed:author | pubmed-author:SomeyaYY | lld:pubmed |
| pubmed-article:18230277 | pubmed:author | pubmed-author:YoshiharaRR | lld:pubmed |
| pubmed-article:18230277 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18230277 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:18230277 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18230277 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18230277 | pubmed:pagination | 137-46 | lld:pubmed |
| pubmed-article:18230277 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:meshHeading | pubmed-meshheading:18230277... | lld:pubmed |
| pubmed-article:18230277 | pubmed:articleTitle | Effects of high-monounsaturated fatty acid enteral formula versus high-carbohydrate enteral formula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients. | lld:pubmed |
| pubmed-article:18230277 | pubmed:affiliation | Division of Diabetes and Endocrinology, Department of Internal Medicine, Jikei Daisan University Hospital, Komae City, Tokyo, Japan. jyoko@jikei.ac.jp | lld:pubmed |
| pubmed-article:18230277 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18230277 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
